Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYNPO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APOL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRANK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on